1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 548 F.Supp.2d
  5. 548 F.Supp.2d 1126 (2008)
 

IN RE DURA PHARMACEUTICALS, INC. SECURITIES LIT.

No. 99CV0151 JLS (WMc).

548 F.Supp.2d 1126 (2008)

In re DURA PHARMACEUTICALS, INC. SECURITIES LITIGATION. This Document Relates To: All Actions.

United States District Court, S.D. California.

February 20, 2008.

Attorney(s) appearing for the Case

Michael D. Donovan, Donovan Searles, Philadelphia, PA, Steven J. Toll, Cohen Milstein Hausfeld & Toll, Washington, DC, William S. Lerach, Lerach Coughlin Stoia Geller Rudman and Robbins, Jeffrey R. Krinsk, Finkelstein and Krinsk, San Diego, CA, William F. Sullivan, Paul, Hastings, Janofsky & Walker LLP, Timothy J. Burke, Stull Stull and Brody, Los Angeles, CA, for Plaintiff.

William F. Sullivan, Paul, Hastings, Janofsky & Walker LLP, Los Angeles, CA, for Defendant.

ORDER GRANTING IN PART WITHOUT PREJUDICE AND DENYING IN PART MOTION TO DISMISS FOURTH CONSOLIDATED AMENDED COMPLAINT

JAMS L. SAMMARTINO, District Judge.

This is a putative class action for securities fraud. Presently before the Court is the motion to dismiss the Fourth Consolidated Amended Complaint ("FCAC") by defendants Dura Pharmaceuticals, Inc. ("Dura"); Cam L. Garner; James W. Newman; Charles W. Prettyman; and Walter F. Spath (collectively, "defendants...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases